(Q73676140)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764917%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

The anxiolytic-like properties of two selective MAOIs, moclobemide and selegiline, in a standard and an enhanced light/dark aversion test (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764917%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

L De Angelis

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764917%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C Furlan

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764917%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 April 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764917%20AND%20SRC:MED&resulttype=core&format=json

Pharmacology, Biochemistry and Behavior

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764917%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764917%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764917%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

649-653

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764917%20AND%20SRC:MED&resulttype=core&format=json

Anxiogenic effects of methyl-beta-carboline-3-carboxylate in a light/dark choice situation.

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900237-3

7 January 2021

A reversible monoamine oxidase A inhibitor (moclobemide) facilitates smoking cessation and abstinence in heavy, dependent smokers*

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900237-3

7 January 2021

The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900237-3

7 January 2021

Experimental anxiety and antidepressant drugs: the effects of moclobemide, a selective reversible MAO-A inhibitor, fluoxetine and imipramine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900237-3

7 January 2021

Biochemistry and pharmacology of moclobemide, a prototype RIMA

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900237-3

7 January 2021

Changes in spontaneous behavior in the dog following oral administration of L-deprenyl

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900237-3

7 January 2021

Novel (-)deprenyl-derived selective inhibitors of B-type monoamine oxidase. The relation of structure to their action

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900237-3

7 January 2021

Behavioral analogues of anxiety animal models

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900237-3

7 January 2021

Clinical pharmacokinetics of the monoamine oxidase-A inhibitor moclobemide

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900237-3

7 January 2021

Effects of chronic oral administration of L-deprenyl in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900237-3

7 January 2021

Effects of moclobemide on forced-swimming stress and brain monoamine levels in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900237-3

7 January 2021

Neuropharmacological and physiological validation of a computer-controlled two-compartment black and white box for the assessment of anxiety

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900237-3

7 January 2021

Species-specific biotransformation of moclobemide: a comparative study in rats and humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900237-3

7 January 2021

Clinical overview on moclobemide

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900237-3

7 January 2021

Use of moclobemide in children with attention deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900237-3

7 January 2021

Monoamine oxidase-B inhibition: a comparison of in vivo and ex vivo measures of reversible effects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900237-3

7 January 2021

Does selegiline delay progression of Parkinson's disease? A critical re-evaluation of the DATATOP study.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900237-3

7 January 2021

A fully automated light/dark apparatus useful for comparing anxiolytic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2899%2900237-3

7 January 2021

10.1016/S0091-3057(99)00237-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10764917%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference